Aerosolized ribavirin: the most expensive drug for pneumonia. Issue 4 (5th July 2016)

• Record Type: Journal Article
• Authors: Chemaly, R.F.; Aitken, S.L.; Wolfe, C.R.; Jain, R.; Boeckh, M.J.
• Is Part Of: Transplant infectious disease. Volume 18:Issue 4(2016)
• Page Start: 634
• Page End: 636
• Publication Date: 2016-07-05
• Subjects: hematopoietic stem cell transplantation -- hematologic malignancy -- cost -- average wholesale price -- pediatrics -- respiratory syncytial virus; Transplantation of organs, tissues, etc -- Complications -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 617.01
• DOI: 10.1111/tid.12551
• Languages: English
• ISSNs: 1398-2273

Abstract

Abstract: Dramatic, overnight cost increases of important orphan and generic medications have recently come under public and government scrutiny. We highlight the case of aerosolized ribavirin, an important antiviral agent in hematopoietic stem cell transplantation which, because of substantial price increases, may now cost more than the transplant procedure itself.